News

Hims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
Granules India receives one observation from USFDA following inspection at U.S. facility
Granules India announced that its wholly-owned foreign subsidiary, located in Chantilly, Virginia, USA, has received one observation in Form 483 from the United States Food and Drug Administration ...
Texas Bans Lab-Grown Meat, Citing Consumer Protection and Agricultural Interests
The state becomes the seventh in the United States to prohibit the sale of meat cultivated from animal cells.Key PointsTexas ...
Telehealth abortions are on the rise since Roe was overturned three years ago. See charts
Since Roe v. Wade was overturned in 2022, monthly abortions have increased each year, a new report shows. Abortion pills, ...
AstraZeneca (AZN) Scores FDA Approval for Datroway, First TROP2 ADC for Lung Cancer
AstraZeneca PLC (NASDAQ:AZN) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company announced that the FDA had granted accelerated approval to Datroway for the treatment ...